FRAGMATIC: a randomised phase III clinical trial investigating the effect of fragmin added to standard therapy in patients with lung cancer - Griffiths, GO; Burns, S; Noble, SI; Macbeth, FR; Cohen, D; Maughan, TS (BMC Cancer, 2009)